• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传咨询、基因检测与乳腺癌和结直肠癌风险认知:来自 2015 年全国健康访谈调查的结果。

Genetic counseling, genetic testing, and risk perceptions for breast and colorectal cancer: Results from the 2015 National Health Interview Survey.

机构信息

National Human Genome Research Institute, Bethesda, MD, United States of America; University of Technology Sydney, NSW, Australia.

National Cancer Institute, Rockville, MD, United States of America.

出版信息

Prev Med. 2019 Jun;123:12-19. doi: 10.1016/j.ypmed.2019.02.027. Epub 2019 Feb 25.

DOI:10.1016/j.ypmed.2019.02.027
PMID:30817954
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7321923/
Abstract

We examined what proportion of the U.S. population with no personal cancer history reported receiving either genetic counseling or genetic testing for cancer risk, and also the association of these behaviors with cancer risk perceptions. We used data from the 2015 National Health Interview Survey. Objective relative risk scores for breast (women) and colorectal (men and women) cancer risk were generated for individuals without a personal history of cancer. Participants' risk perceptions were compared with their objective relative risk. Of 12,631 women, 1.2% reported receiving genetic counseling and 0.8% genetic testing for hereditary breast cancer risk. Of 15,085 men and women, 0.8% reported receiving genetic counseling and 0.3% genetic testing for hereditary colorectal cancer risk. Higher breast cancer risk perception was associated with genetic counseling (OR: 4.31, 95%CI: 2.56, 7.26) and testing (OR: 3.56, 95%CI: 1.80, 7.03). Similarly, higher perception of colorectal cancer risk was associated with genetic counseling (OR: 5.04, 95%CI: 2.57, 9.89) and testing (OR: 5.92, 95%CI: 2.40, 14.63). A higher proportion of individuals with colorectal cancer risk perceptions concordant with their objective risk (vs. discordant) had undergone genetic counseling or testing for colorectal cancer risk. Concordant risk perceptions for breast cancer were not associated with breast cancer genetic counseling or testing. Given frequent dialogue about implementing population level programs involving genetic services for cancer risk, policy makers and investigators should consider the role of risk perceptions in the effectiveness and design of such programs and potential strategies for addressing inaccuracies in risk perceptions.

摘要

我们研究了没有个人癌症病史的美国人口中,有多少人接受了癌症风险的遗传咨询或基因检测,以及这些行为与癌症风险认知的关系。我们使用了 2015 年全国健康访谈调查的数据。为没有个人癌症史的个体生成了乳腺癌(女性)和结直肠癌(男性和女性)风险的客观相对风险评分。将参与者的风险认知与他们的客观相对风险进行比较。在 12631 名女性中,1.2%报告接受了遗传性乳腺癌风险的遗传咨询,0.8%接受了基因检测。在 15085 名男性和女性中,0.8%报告接受了遗传性结直肠癌风险的遗传咨询,0.3%接受了基因检测。更高的乳腺癌风险认知与遗传咨询(OR:4.31,95%CI:2.56,7.26)和检测(OR:3.56,95%CI:1.80,7.03)相关。同样,更高的结直肠癌风险认知与遗传咨询(OR:5.04,95%CI:2.57,9.89)和检测(OR:5.92,95%CI:2.40,14.63)相关。与客观风险不一致的个体中,有更高比例的人接受了结直肠癌风险的遗传咨询或检测。而与结直肠癌风险认知一致的个体,则与乳腺癌的遗传咨询或检测无关。鉴于经常讨论实施涉及癌症风险的遗传服务的人群水平计划,政策制定者和研究人员应考虑风险认知在这些计划的有效性和设计中的作用,以及解决风险认知不准确的潜在策略。

相似文献

1
Genetic counseling, genetic testing, and risk perceptions for breast and colorectal cancer: Results from the 2015 National Health Interview Survey.遗传咨询、基因检测与乳腺癌和结直肠癌风险认知:来自 2015 年全国健康访谈调查的结果。
Prev Med. 2019 Jun;123:12-19. doi: 10.1016/j.ypmed.2019.02.027. Epub 2019 Feb 25.
2
Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.医疗机构与美国 BRCA 基因突变风险女性讨论基因检测。
Am J Prev Med. 2018 Feb;54(2):221-228. doi: 10.1016/j.amepre.2017.10.015. Epub 2017 Dec 11.
3
Low Rates of Genetic Counseling and Testing in Individuals at Risk for Lynch Syndrome Reported in the National Health Interview Survey.《国家健康访谈调查》报告显示,林奇综合征高危个体的遗传咨询和检测率较低。
Gastroenterology. 2020 Mar;158(4):1159-1161. doi: 10.1053/j.gastro.2019.11.297. Epub 2019 Dec 6.
4
Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.有乳腺癌或卵巢癌家族史的女性在BRCA1/2检测使用方面的种族差异。
JAMA. 2005 Apr 13;293(14):1729-36. doi: 10.1001/jama.293.14.1729.
5
Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.BRCA 基因检测和咨询在全国商业保险人群中的利用和结果:ABOUT 研究。
JAMA Oncol. 2015 Dec;1(9):1251-60. doi: 10.1001/jamaoncol.2015.3048.
6
Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk.临床BRCA1/2检测的早期应用:与种族和乳腺癌风险的关联
Am J Med Genet A. 2003 Mar 1;117A(2):154-60. doi: 10.1002/ajmg.a.10928.
7
Clinical characterization and risk profile of individuals seeking genetic counseling for hereditary breast cancer in Brazil.巴西遗传性乳腺癌基因咨询个体的临床特征与风险概况
J Genet Couns. 2007 Jun;16(3):363-71. doi: 10.1007/s10897-006-9073-0. Epub 2007 Feb 23.
8
Painting a portrait: Analysis of national health survey data for cancer genetic counseling.绘制画像:对国家癌症遗传咨询健康调查数据的分析。
Cancer Med. 2019 Mar;8(3):1306-1314. doi: 10.1002/cam4.1864. Epub 2019 Feb 7.
9
Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.基于计算机的决策辅助工具对乳腺癌易感性基因检测的知识、认知及意愿的影响:一项随机对照试验。
JAMA. 2004 Jul 28;292(4):442-52. doi: 10.1001/jama.292.4.442.
10
Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing.男性乳腺癌风险评估和筛查建议在接受遗传咨询和多基因panel 检测的高危男性中。
Clin Breast Cancer. 2021 Feb;21(1):e74-e79. doi: 10.1016/j.clbc.2020.07.014. Epub 2020 Jul 25.

引用本文的文献

1
Association between cancer screenings uptake and genetic testing for cancer risk among US adults: findings from HINTS 2017-2020.美国成年人癌症筛查接受情况与癌症风险基因检测之间的关联:2017 - 2020年健康信息国家趋势调查(HINTS)的结果
J Community Genet. 2025 Apr 30. doi: 10.1007/s12687-025-00797-0.
2
Evidence-based advancements in breast cancer genetic counseling: a review.乳腺癌遗传咨询的循证进展:综述
Breast Cancer. 2025 Mar;32(2):258-277. doi: 10.1007/s12282-024-01660-9. Epub 2024 Dec 17.
3
Experiences across a genetic screening and testing programme pathway: a qualitative study of mammogram patient perspectives.遗传筛查和检测计划路径中的体验:对乳房 X 光照片患者观点的定性研究。
BMJ Open. 2024 Oct 23;14(10):e089884. doi: 10.1136/bmjopen-2024-089884.
4
Patient decision support resources inform decisions about cancer susceptibility genetic testing and risk management: a systematic review of patient impact and experience.患者决策支持资源为癌症易感性基因检测和风险管理决策提供信息:对患者影响和体验的系统评价
Front Health Serv. 2023 May 31;3:1092816. doi: 10.3389/frhs.2023.1092816. eCollection 2023.
5
Risk perception of non-communicable diseases: A systematic review on its assessment and associated factors.非传染性疾病风险感知:评估及其相关因素的系统评价。
PLoS One. 2023 Jun 1;18(6):e0286518. doi: 10.1371/journal.pone.0286518. eCollection 2023.
6
An spanish study of secondary findings in families affected with mendelian disorders: choices, prevalence and family history.一项针对伴有孟德尔疾病的家族中的二级发现的西班牙研究:选择、患病率和家族史。
Eur J Hum Genet. 2023 Feb;31(2):223-230. doi: 10.1038/s41431-022-01240-5. Epub 2022 Nov 29.
7
Association between Health Insurance Type and Genetic Testing and/or Counseling for Breast and Ovarian Cancer.医疗保险类型与乳腺癌和卵巢癌基因检测及/或咨询之间的关联。
J Pers Med. 2022 Jul 31;12(8):1263. doi: 10.3390/jpm12081263.
8
Estimating lifetime risk for breast cancer as a screening tool for identifying those who would benefit from additional services among women utilizing mobile mammography.作为一种筛查工具,估算乳腺癌终生风险可以帮助确定那些利用移动乳房 X 光检查的女性中,哪些人可以从额外的服务中受益。
J Cancer Policy. 2022 Dec;34:100354. doi: 10.1016/j.jcpo.2022.100354. Epub 2022 Aug 19.
9
Genetic Testing and/or Counseling for Colorectal Cancer by Health Insurance Type.按健康保险类型划分的结直肠癌基因检测和/或咨询
J Pers Med. 2022 Jul 15;12(7):1146. doi: 10.3390/jpm12071146.
10
Prevalence of Americans reporting a family history of cancer indicative of increased cancer risk: Estimates from the 2015 National Health Interview Survey.美国人报告家族癌症史的比例表明癌症风险增加:2015 年国家健康访谈调查的估计。
Prev Med. 2022 Jun;159:107062. doi: 10.1016/j.ypmed.2022.107062. Epub 2022 Apr 20.

本文引用的文献

1
Psychosocial, attitudinal, and demographic correlates of cancer-related germline genetic testing in the 2017 Health Information National Trends Survey.2017年健康信息国家趋势调查中癌症相关种系基因检测的心理社会、态度和人口统计学相关因素。
J Community Genet. 2019 Oct;10(4):453-459. doi: 10.1007/s12687-018-00405-4. Epub 2019 Feb 20.
2
Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.直接面向消费者的基因检测:美国食品药品监督管理局首次批准BRCA突变检测上市的影响
JAMA. 2018 Jun 19;319(23):2377-2378. doi: 10.1001/jama.2018.5330.
3
National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.有乳腺癌或卵巢癌病史女性的基因检测全国估计数。
J Clin Oncol. 2017 Dec 1;35(34):3800-3806. doi: 10.1200/JCO.2017.73.6314. Epub 2017 Aug 18.
4
Perceived physical activity and mortality: Evidence from three nationally representative U.S. samples.感知到的身体活动与死亡率:来自美国三个全国代表性样本的证据。
Health Psychol. 2017 Nov;36(11):1017-1025. doi: 10.1037/hea0000531. Epub 2017 Jul 20.
5
Is there evidence that we should screen the general population for Lynch syndrome with genetic testing? A systematic review.是否有证据表明我们应该通过基因检测对普通人群进行林奇综合征筛查?一项系统评价。
Pharmgenomics Pers Med. 2017 Feb 20;10:49-60. doi: 10.2147/PGPM.S123808. eCollection 2017.
6
Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counselling for hereditary cancer: a systematic review.与遗传性癌症遗传咨询接受情况相关的社会人口学、心理社会和临床因素:一项系统综述
Clin Genet. 2017 Aug;92(2):121-133. doi: 10.1111/cge.12868. Epub 2016 Oct 23.
7
Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.BRCA 基因检测和咨询在全国商业保险人群中的利用和结果:ABOUT 研究。
JAMA Oncol. 2015 Dec;1(9):1251-60. doi: 10.1001/jamaoncol.2015.3048.
8
A Primer on Unrealistic Optimism.关于不切实际的乐观主义的入门指南。
Curr Dir Psychol Sci. 2015 Jun;24(3):232-237. doi: 10.1177/0963721414568341.
9
ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.ACG 临床指南:遗传性胃肠道癌综合征的基因检测与管理。
Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263. doi: 10.1038/ajg.2014.435. Epub 2015 Feb 3.
10
Prevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: findings from the Health Information National Trends Survey.接受和分享高穿透性癌症基因检测结果的患病率及其相关因素:来自健康信息国家趋势调查的结果
Public Health Genomics. 2015;18(2):67-77. doi: 10.1159/000368745.